Understanding the Role of Targets and Pathways in the Treatment of Melanoma
Incidence rates of melanoma continue to climb, and while most patients are diagnosed at an early stage, once metastatic, melanoma remains the most deadly of all the cutaneous malignancies. With the discovery of immune checkpoints and therapies that target the MAPK pathway, patients with metastatic melanoma have new treatment options and renewed hope.
Posted: 11/27/2018 / Expires: 11/27/2019
Estimated time to complete: 3 hours